MRI IN THE ASSESSMENT OF TUMOR RESPONSE TO CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER

MRI IN THE ASSESSMENT OF TUMOR RESPONSE TO CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER

Objective: to evaluate the ability of high-field MRI to assess tumor response to chemoradiotherapy in patients with locally advanced cervical cancer. Material and methods. The study involved 43 patients. MRI was performed using a 1.5 Tesla MAGNETOM ESSENZA scanner (SIEMENS, Germany) with a magnetic...

Full description

Bibliographic Details
Main Authors:	N. G. Trukhacheva, I. G. Frolova, L. A. Kolomiets, A. V. Usova, E. G. Grigorjev, S. A. Velichko, O. N. Churuksaeva, O. V. Shpileva
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	resonance imaging, cervical cancer, response to chemoradiotherapy
Online Access:	https://www.siboncoj.ru/jour/article/view/174

Similar Items

ASSESSMENT OF THE EXTENT OF CERVICAL CANCER SPREAD USING MAGNETIC RESONANCE IMAGING
by: N. G. Trukhacheva, et al.
Published: (2016-02-01)

Novel approaches to diagnostic imaging of locally advanced cervical cancer
by: N. G. Trukhacheva, et al.
Published: (2019-04-01)

MRI delta radiomics during chemoradiotherapy for prognostication in locally advanced cervical cancer
by: Kari S. Wagner-Larsen, et al.
Published: (2025-01-01)

Potentialities of multi-b-values diffusion-weighted imaging for predicting efficacy of concurrent chemoradiotherapy in cervical cancer patients
by: Bing Liu, et al.
Published: (2020-08-01)

Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy
by: Raminta Stuopelytė, et al.
Published: (2023-04-01)

Tumor endothelium-derived PODXL correlates with immunosuppressive microenvironment and poor prognosis in cervical cancer patients receiving radiotherapy or chemoradiotherapy
by: Rui Huang, et al.
Published: (2024-09-01)

LOCAL HYPERTHERMIA IN THE TREATMNET OF LOCALLY ADVANCED CERVICAL CANCER: CURRENT VIEW ON THE PROBLEM
by: O. V. Shpileva, et al.
Published: (2021-08-01)

Is Surgical Treatment an Option for Locally Advanced Cervical Cancer in the Presence of Central Residual Tumor after Chemoradiotherapy?
by: Samet Topuz, et al.
Published: (2020-03-01)

Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women
by: Weiping Wang, et al.
Published: (2017-08-01)

The Influence of Cisplatin Dose upon Survival in Concurrent Chemoradiotherapy of Locally Advanced Cervical Carcinoma with Weekly Cisplatin
by: Igor Sirák, et al.
Published: (2008-01-01)

Longitudinal dynamic MRI radiomic models for early prediction of prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy
by: Chang Cai, et al.
Published: (2024-12-01)

Correlation Between Akt and p53 Protein Expression and Chemoradiotherapy Response in Cervical Cancer Patients
by: IIN KURNIA, et al.
Published: (2014-12-01)

Impact of chemoradiotherapy on vaginal and sexual function of patients with FIGO IIb cervical cancer
by: Dženita Ljuca, et al.
Published: (2011-02-01)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
by: Akihiko Wakayama, et al.
Published: (2017-08-01)

Outcome and prognostic factors in cervical cancer patients treated with surgery and concurrent chemoradiotherapy: a retrospective study
by: Yan-Mei Liu, et al.
Published: (2018-01-01)

Quantitative analysis of superb microvascular imaging for monitoring tumor response to chemoradiotherapy in locally advanced cervical cancer
by: Yi Zhu, et al.
Published: (2023-01-01)

Changes in magnetic resonance imaging T2-weighted imaging signal intensity correlated with concurrent chemoradiotherapy response in cervical cancer
by: Bing Liu, et al.
Published: (2019-02-01)

Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer
by: Weiwei Li, et al.
Published: (2023-03-01)

Radiomics feature is a risk factor for locally advanced cervical cancer treated using concurrent chemoradiotherapy based on magnetic resonance imaging: a retrospective study
by: Yuan Wang, et al.
Published: (2025-02-01)

Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis
by: Haonan Liu, et al.
Published: (2022-12-01)

A CASE OF MULTIPLE PRIMARY CANCER: SYNCHRONOUS CERVICAL ADENOCARCINOMA AND SQUAMOUS CELL OVARIAN CARCINOMA
by: S. V. Molchanov, et al.
Published: (2016-04-01)

Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer
by: Satomi Hattori, et al.
Published: (2021-04-01)

The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma
by: Jia-Zhen Xu, et al.
Published: (2017-04-01)

ONCOTROPIC PAPILLOMAVIRUS INFECTION AND PROgNOSis FOR PATIENTS WITH CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy
by: Cheng Ming, et al.
Published: (2023-10-01)

Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials
by: Yan Yuan, et al.
Published: (2022-10-01)

MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapy
by: Qi Yan, et al.
Published: (2024-10-01)

Multimodal treatment with chemoradiotherapy, regional hyperthermia and interstitial brachytherapy for a huge locally advanced cervical cancer: A case report
by: Takashi Saito, et al.
Published: (2023-12-01)

Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy
by: Xin-xin Du, et al.
Published: (2019-05-01)

Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
by: Mei-ling Zhong, et al.
Published: (2024-02-01)

Risk Prediction Model for Radiation-induced Dermatitis in Patients with Cervical Carcinoma Undergoing Chemoradiotherapy
by: Hong Yang, et al.
Published: (2024-05-01)

Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis
by: Kang Qi, et al.
Published: (2023-05-01)

Correlation between changes of pelvic bone marrow fat content and hematological toxicity in concurrent chemoradiotherapy for cervical cancer
by: Cong Wang, et al.
Published: (2022-04-01)

Ultrasound with use of Doppler for assess the effectiveness of chemoradiotherapy for cervical cancer
by: T. E. Gorbushina, et al.
Published: (2015-08-01)

Effect of Endostar combined with concurrent chemoradiotherapy in patients with locally advanced cervical cancer
by: Hengzhao Zhuang, et al.
Published: (2023-06-01)

Outcomes of combination therapy for stage IIA–IIIB cervical cancer
by: D. K. Reyes Santiago, et al.
Published: (2019-02-01)

Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study
by: Jing You, et al.
Published: (2024-07-01)

Association of body composition and systemic inflammation for patients with locally advanced cervical cancer following concurrent chemoradiotherapy
by: Juan Li, et al.
Published: (2024-09-01)

Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
by: Jing Liu, et al.
Published: (2022-08-01)

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)